Two posters presented at the 2024 American Society of Hematology meeting reported real-world outcomes data for patients ...
The Barbara Ann Karmanos Cancer Institute welcomes José Larios, M.D., transplant hematologist. Dr. Larios is a member of the ...
Dr. Sattva S. Neelapu discusses the intricacies of CAR T-cell therapy treatment and care for patients with hematologic ...
Robert M. Rifkin, MD, FACP, discusses how the MagnetisMM-3 update at the 66th American Society of Hematology Annual Meeting and Exposition sheds light on elranatamab’s role in relapsed/refractory ...
Akriti Jain, MD, discusses her presentation from the 2024 American Society of Hematology Meeting and Exposition.
Anglo-Swedish drugmaker AstraZeneca has announced that new, positive, long-term results from the pivotal ALPHA Phase III ...
The top U.S. health official is calling for all alcoholic beverages to carry a warning label about cancer risk.
Tafasitamab increased progression free survival by about 9 months when compared to placebo, according to recent study data.
Researchers developed a novel calculator may help to tailor pain medication regimens to patients with SCD seeking emergency ...
Learn about pediatric low-grade glioma symptoms, causes, diagnosis, and treatment. Understand risk factors and prevention to ...
The Healthy on MSN5d
11 Common Illnesses That Have Been Linked to Alzheimer’sAlthough we don't know a lot about the causes of Alzheimer's disease, the following conditions may raise your risk.
Mendus AB ("Mendus" publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, announces a summary of the feedback received from the US Food and Drug Administr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback